Nicorandil attenuates myocardial acidosis during coronary occlusion in dogs. 1984

Y Abiko, and T Nishimura, and K Sakai

In dogs anaesthetized with pentobarbitone, the left anterior descending coronary artery (LAD) was partially occluded. Before and 30 min after partial occlusion, the myocardial pH was 7.52-7.54 and 6.89-6.91, respectively. Nicorandil (50 micrograms kg-1, i.v.) increased the pH that had been reduced by partial occlusion and this effect lasted at least 60 min. Thus nicorandil attenuates ischaemic myocardial acidosis.

UI MeSH Term Description Entries
D008297 Male Males
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D020108 Nicorandil A derivative of the NIACINAMIDE that is structurally combined with an organic nitrate. It is a potassium-channel opener that causes vasodilatation of arterioles and large coronary arteries. Its nitrate-like properties produce venous vasodilation through stimulation of guanylate cyclase. 2-Nicotinamidoethyl Nitrate,2-Nicotinamidethyl Nitrate,Adancor,Dancor,Ikorel,SG-75,2 Nicotinamidethyl Nitrate,2 Nicotinamidoethyl Nitrate,Nitrate, 2-Nicotinamidethyl,Nitrate, 2-Nicotinamidoethyl,SG 75,SG75

Related Publications

Y Abiko, and T Nishimura, and K Sakai
January 1990, Archives internationales de pharmacodynamie et de therapie,
Y Abiko, and T Nishimura, and K Sakai
June 1989, Methods and findings in experimental and clinical pharmacology,
Y Abiko, and T Nishimura, and K Sakai
April 1988, The Journal of pharmacology and experimental therapeutics,
Y Abiko, and T Nishimura, and K Sakai
August 1989, Naunyn-Schmiedeberg's archives of pharmacology,
Y Abiko, and T Nishimura, and K Sakai
September 1987, The Journal of pharmacology and experimental therapeutics,
Y Abiko, and T Nishimura, and K Sakai
January 1994, Archives internationales de pharmacodynamie et de therapie,
Y Abiko, and T Nishimura, and K Sakai
September 1993, Circulation research,
Y Abiko, and T Nishimura, and K Sakai
January 1988, Journal of cardiovascular pharmacology,
Y Abiko, and T Nishimura, and K Sakai
January 1987, Basic research in cardiology,
Copied contents to your clipboard!